#USA #New York #Levi & Korsinsky #class action lawsuit #uniQure N.V.

Overview of the uniQure N.V. Class Action Lawsuit

uniQure N.V., traded on NASDAQ under the ticker symbol QURE, is currently facing a class action lawsuit initiated by the esteemed law firm Levi & Korsinsky, LLP. This action comes after allegations of securities fraud that might have adversely impacted investors. Understanding the implications and deadlines for affected investors is crucial for anyone who holds shares in uniQure.

What Led to the Lawsuit?

The class action lawsuit covers allegations made against uniQure that occurred between September 24, 2025, and October 31, 2025. During this period, it is claimed that uniQure's management made false statements and concealed critical information regarding the approval of its Pivotal Study by the FDA. This study was central to the company's Biologics License Application (BLA). Allegations include that the company downplayed the potential need for additional studies before submitting its BLA, which could lead to delays in approval.

Impact on Investors

Investors who suffered losses during the specified timeframe may be eligible to participate in the class action lawsuit. The court has set a deadline of April 13, 2026, for investors to request being appointed as lead plaintiffs. However, it’s important to note that participation does not require one to be a lead plaintiff, and compensation may be obtained without incurring out-of-pocket costs.

Levi & Korsinsky's Track Record

The firm leading this lawsuit, Levi & Korsinsky, has a long-standing reputation in the field of securities litigation. Over the past 20 years, they have successfully recovered hundreds of millions of dollars for shareholders. Their extensive experience in complex litigation makes them a formidable advocate for investors seeking justice in cases of securities fraud.

Next Steps for Affected Investors

For those who believe they have been affected by the alleged fraud, it’s advisable to act promptly due to the approaching deadline. Interested investors can contact Levi & Korsinsky directly via email or telephone to discuss their situation. They can provide insight and assistance regarding how to proceed with the lawsuit.

Contact Information

• - Email: email
• - Telephone: (212) 363-7500
• - Address:

Levi & Korsinsky, LLP
33 Whitehall Street, 27th Floor
New York, NY 10004.

Conclusion

The uniQure class action lawsuit represents a critical moment for investors in the company. As the allegations unfold, investors must stay informed and seek professional guidance if they believe they may be part of the affected group. With a reputable law firm navigating this case, there's potential for recovery of losses, making it imperative for affected investors to engage with legal counsel and take action before the deadline passes.